Eric P. Lefkofsky Sells 476,209 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 476,209 shares of the firm’s stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $49.84, for a total value of $23,734,256.56. Following the transaction, the chief executive officer now owns 6,502,643 shares in the company, valued at approximately $324,091,727.12. This represents a 6.82 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Tempus AI Stock Down 6.3 %

NASDAQ:TEM traded down $3.44 during mid-day trading on Friday, hitting $51.40. 12,994,864 shares of the company’s stock traded hands, compared to its average volume of 9,294,415. The company has a fifty day moving average of $44.38 and a 200 day moving average of $47.46. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on TEM. Bank of America increased their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and increased their price objective for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 target price on the stock. Finally, Piper Sandler reiterated a “neutral” rating and issued a $70.00 price target (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $56.36.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently modified their holdings of TEM. First Horizon Advisors Inc. purchased a new position in Tempus AI in the 3rd quarter worth $30,000. Geode Capital Management LLC increased its holdings in shares of Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after purchasing an additional 539 shares during the period. FNY Investment Advisers LLC purchased a new position in shares of Tempus AI in the fourth quarter worth about $67,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI during the third quarter worth about $153,000. Finally, The Manufacturers Life Insurance Company boosted its position in Tempus AI by 10.2% in the third quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock valued at $1,686,000 after buying an additional 2,765 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.